Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in NRXS — Neuraxis, INC

CIK 1533421 NEW YORK, NY
Back to NRXS Full portfolio

Position in NRXS

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$8,472
+$1,653 QoQ
Shares Held
1,159
-22.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 32 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. NRXS ranks #317 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in NRXS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,472 1,159
2025-12-31 $6,819 1,502
2025-09-30 $4,946 1,606
2025-06-30 $5,190 2,145
2025-03-31 $3,992 1,857
2024-12-31 $5,437 2,314
2024-09-30 $5,662 1,900
2024-06-30 $9,757 3,510
2024-03-31 $8,751 2,805
2023-12-31 $10,615 3,976
2023-09-30 $212 56